Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases | MicrobiomeTrials← Back to trialsNCT07784881
Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases
CompletedOBSERVATIONAL
Trial Details
Start: 2021-04-20Est. Completion: 2025-10-24
Enrollment target: 220 participants Locations- Nantes University Hospital, Nantes, France
Other microbiome trials you might be interested in
Hematopoietic Stem Cell Transplant
Background:
Hematopoietic stem cell transplant (HSCT) is a common treatment for many cancers and other illnesses. But m…
Bethesda, United StatesEst. completion Jun 30, 2031
Primary Immunodeficiency Disorders
Background:
Primary immunodeficiency disorders, or PIDs, are diseases that weaken the immune system. This makes it easi…
Washington D.C., United StatesEst. completion Dec 31, 2029
Non-Alcoholic Fatty Liver Disease
Type2 Diabetes
Type 2 diabetes patients have a high risk of developing NAFLD. This was confirmed during previous research, a high preva…
Genk, BelgiumCompleted Jun 30, 2026